The efficacy and safety of two different doses of caffeine in respiratory function of preterm infants
- PMID: 29387319
- PMCID: PMC5771360
- DOI: 10.22088/cjim.9.1.46
The efficacy and safety of two different doses of caffeine in respiratory function of preterm infants
Abstract
Background: Caffeine is widely used for prevention of apnea and helps successful extubation from mechanical ventilation. It facilitates the transition from invasive to noninvasive support and reduces duration of continuous positive airway pressure (CPAP) in preterm infants. The optimum caffeine dose in preterm infants has not been well-studied in terms of benefits and risks. We compared efficacy and safety of once versus twice-daily caffeine dose in premature infants.
Methods: This study was a randomized clinical trial conducted in Bu-Ali Sina Teaching Hospital, Sari. Patients with gestational age of <37 weeks were included. Both groups received 20 mg/kg loading dose of caffeine intravenously followed by maintenance dose of 5 mg/kg/day in group 1 or 2.5 mg/kg every 12 hours in group 2. Extubation failure, CPAP failure and possibly adverse reactions were evaluated.
Results: The mean of gestational age and birth weight were 32.27±3.23 (weeks) and 1824.5±702.54 (gr), respectively. The rate of extubation and CPAP failure and length of NICU stay were lower in twice-daily-group with no statistically significant difference. The means of O2 saturations on the first three days of caffeine therapy were higher in twice-daily-group. Caffeine was generally safe and well tolerated.
Conclusions: This study, which assayed short-term effects of caffeine, showed that twice daily caffeine maintenance dose was related to more benefits in facilitating extubation or prevention of CPAP failure in preterm infants. However, there was not statistically significant difference between two groups.
Keywords: CPAP failure; Caffeine; Extubation failure; Preterm infants.
Conflict of interest statement
There is no conflict of interest.
Similar articles
-
Caffeine citrate maintenance doses effect on extubation and apnea postventilation in preterm infants.Pediatr Pulmonol. 2020 Oct;55(10):2635-2640. doi: 10.1002/ppul.24948. Epub 2020 Jul 15. Pediatr Pulmonol. 2020. PMID: 32639634 Clinical Trial.
-
A randomized controlled trial of post-extubation bubble continuous positive airway pressure versus Infant Flow Driver continuous positive airway pressure in preterm infants with respiratory distress syndrome.J Pediatr. 2009 May;154(5):645-50. doi: 10.1016/j.jpeds.2008.12.034. Epub 2009 Feb 23. J Pediatr. 2009. PMID: 19230906 Clinical Trial.
-
High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.Eur J Pediatr. 2015 Jul;174(7):949-56. doi: 10.1007/s00431-015-2494-8. Epub 2015 Feb 3. Eur J Pediatr. 2015. PMID: 25644724 Clinical Trial.
-
High-versus low-dose caffeine in preterm infants: a systematic review and meta-analysis.Acta Paediatr. 2019 Mar;108(3):401-410. doi: 10.1111/apa.14586. Epub 2018 Oct 30. Acta Paediatr. 2019. PMID: 30242903
-
Caffeine in preterm infants: where are we in 2020?ERJ Open Res. 2020 Mar 2;6(1):00330-2019. doi: 10.1183/23120541.00330-2019. eCollection 2020 Jan. ERJ Open Res. 2020. PMID: 32154294 Free PMC article. Review.
Cited by
-
Caffeine Treatment for Apnea of Prematurity and the Influence on Dose-Dependent Postnatal Weight Gain Observed Over 15 Years.J Caffeine Adenosine Res. 2018 Sep 1;8(3):99-106. doi: 10.1089/caff.2018.0005. J Caffeine Adenosine Res. 2018. PMID: 30250944 Free PMC article.
-
Dose-Response Study of Caffeine on Postnatal Weight Gain in Premature Neonates-A Retrospective Cohort Study.Dose Response. 2024 Apr 13;22(2):15593258241247185. doi: 10.1177/15593258241247185. eCollection 2024 Apr-Jun. Dose Response. 2024. PMID: 38617389 Free PMC article.
-
A Randomized Controlled Trial Comparing Two Doses of Caffeine for Apnoea in Prematurity.Int J Environ Res Public Health. 2021 Apr 23;18(9):4509. doi: 10.3390/ijerph18094509. Int J Environ Res Public Health. 2021. PMID: 33922783 Free PMC article. Clinical Trial.
-
Predictors for poor daily weight gain in preterm neonates exposed to different dose regimens of caffeine in ICU- a retrospective cohort study.BMC Pediatr. 2024 Jun 20;24(1):401. doi: 10.1186/s12887-024-04850-8. BMC Pediatr. 2024. PMID: 38898410 Free PMC article.
References
-
- Edwards MO, Kotecha SJ, Kotecha S. Respiratory distress of the term newborn infant. Paediatr Respir Rev. 2013;14:29–37. - PubMed
-
- Subiramanian S, Sweet DG. Management of neonatal respiratory distress syndrome. Paediatr Child Health. 2012;22:518–22.
-
- Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome-2016 update. Neonatology. 2016;111:107–25. - PubMed
LinkOut - more resources
Full Text Sources
Medical